Published in Blood on October 16, 2007
Compound haploinsufficiencies of Ebf1 and Runx1 genes impede B cell lineage progression. Proc Natl Acad Sci U S A (2010) 1.09
Early B cell factor: Regulator of B lineage specification and commitment. Semin Immunol (2008) 1.07
Signaling proteins and transcription factors in normal and malignant early B cell development. Bone Marrow Res (2011) 0.89
HDAC8 Inhibition Specifically Targets Inv(16) Acute Myeloid Leukemic Stem Cells by Restoring p53 Acetylation. Cell Stem Cell (2015) 0.86
A germline point mutation in Runx1 uncouples its role in definitive hematopoiesis from differentiation. Exp Hematol (2013) 0.80
Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they? Haematologica (2012) 0.80
Regain control of p53: Targeting leukemia stem cells by isoform-specific HDAC inhibition. Exp Hematol (2016) 0.79
CBFβ and the leukemogenic fusion protein CBFβ-SMMHC associate with mitotic chromosomes to epigenetically regulate ribosomal genes. J Cell Biochem (2014) 0.77
CBFβ-SMMHC creates aberrant megakaryocyte-erythroid progenitors prone to leukemia initiation in mice. Blood (2016) 0.75
Charged Amino Acid-rich Leucine Zipper-1 (Crlz-1) as a Target of Wnt Signaling Pathway Controls Pre-B Cell Proliferation by Affecting Runx/CBFβ-targeted VpreB and λ5 Genes. J Biol Chem (2016) 0.75
Ectopic Runx1 expression rescues Tal-1-deficiency in the generation of primitive and definitive hematopoiesis. PLoS One (2013) 0.75
The assembly competence domain is essential for inv(16)-associated acute myeloid leukemia. Leukemia (2017) 0.75
Inducible gene targeting in mice. Science (1995) 21.22
Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell (1997) 12.60
AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell (1996) 9.74
Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity (2002) 8.17
Oncogenic transcription factors in the human acute leukemias. Science (1997) 6.45
Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci U S A (1996) 6.29
E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell (1994) 5.41
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J (1996) 5.17
The helix-loop-helix gene E2A is required for B cell formation. Cell (1994) 4.59
Thymopoiesis independent of common lymphoid progenitors. Nat Immunol (2003) 4.52
Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development (1999) 4.21
Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature (1995) 4.14
AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat Med (2004) 4.00
Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science (1993) 3.88
The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo. Cell (1996) 3.55
Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha. Virology (1993) 3.37
Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood (2005) 3.32
Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol Cell Biol (1993) 3.07
Long-term cultured E2A-deficient hematopoietic progenitor cells are pluripotent. Immunity (2004) 2.37
Contingent gene regulatory networks and B cell fate specification. Proc Natl Acad Sci U S A (2005) 2.36
Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. Immunity (1999) 2.35
Reversion of B cell commitment upon loss of Pax5 expression. Science (2002) 2.16
The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia. Nat Genet (1999) 2.02
Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation. EMBO J (2001) 1.89
Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia. Cancer Cell (2006) 1.88
Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell (1996) 1.84
Early B cell factor promotes B lymphopoiesis with reduced interleukin 7 responsiveness in the absence of E2A. J Exp Med (2004) 1.83
Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription. Nat Immunol (2004) 1.82
Upstream and downstream targets of RUNX proteins. J Cell Biochem (2003) 1.71
AML1(-/-) embryos do not express certain hematopoiesis-related gene transcripts including those of the PU.1 gene. Oncogene (1998) 1.67
Requirement of Runx1/AML1/PEBP2alphaB for the generation of haematopoietic cells from endothelial cells. Genes Cells (2001) 1.65
PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors. Immunity (1997) 1.64
The earliest step in B lineage differentiation from common lymphoid progenitors is critically dependent upon interleukin 7. J Exp Med (2002) 1.61
B lineage-specific regulation of V(D)J recombinase activity is established in common lymphoid progenitors. J Exp Med (2004) 1.53
A conserved transcriptional enhancer regulates RAG gene expression in developing B cells. Immunity (2003) 1.50
A common pathway for dendritic cell and early B cell development. J Immunol (2001) 1.50
Role of RUNX1 in adult hematopoiesis: analysis of RUNX1-IRES-GFP knock-in mice reveals differential lineage expression. Blood (2003) 1.46
E47 is required for V(D)J recombinase activity in common lymphoid progenitors. J Exp Med (2005) 1.44
Functional assessment of precursors from murine bone marrow suggests a sequence of early B lineage differentiation events. Immunity (2000) 1.42
Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia. Proc Natl Acad Sci U S A (2004) 1.30
Core-binding factor: a central player in hematopoiesis and leukemia. Cancer Res (1999) 1.23
Transcription factor Pax5 (BSAP) transactivates the RAG-mediated V(H)-to-DJ(H) rearrangement of immunoglobulin genes. Nat Immunol (2006) 1.23
Differentiation of B lymphocytes from hematopoietic stem cells. Methods Mol Biol (2004) 1.15
The AML1 transcription factor functions to develop and maintain hematogenic precursor cells in the embryonic aorta-gonad-mesonephros region. Dev Biol (2000) 1.04
Role of Cbfb in hematopoiesis and perturbations resulting from expression of the leukemogenic fusion gene Cbfb-MYH11. Blood (2002) 1.03
Overlapping expression of early B-cell factor and basic helix-loop-helix proteins as a mechanism to dictate B-lineage-specific activity of the lambda5 promoter. Mol Cell Biol (2000) 1.01
Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations. Blood (1995) 0.99
The B29 (immunoglobulin beta-chain) gene is a genetic target for early B-cell factor. Mol Cell Biol (1999) 0.95
Developmental separation of V(D)J recombinase expression and initiation of IgH recombination in B lineage progenitors in vivo. J Exp Med (2004) 0.94
Pearson correlation analysis of microarray data allows for the identification of genetic targets for early B-cell factor. J Biol Chem (2004) 0.92
Early B cell factor is an activator of the B lymphoid kinase promoter in early B cell development. J Immunol (1999) 0.91
AML1 (CBFalpha2) cooperates with B cell-specific activating protein (BSAP/PAX5) in activation of the B cell-specific BLK gene promoter. J Biol Chem (1999) 0.88
An inv(16)(p13q22) positive acute myeloid leukaemia relapsing as acute precursor B-cell lymphoblastic leukaemia. Haematologica (2004) 0.84
PEBP2 and c-myb sites crucial for lambda5 core enhancer activity in pre-B cells. Eur J Immunol (2001) 0.83
Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia. Blood (1995) 0.82
Clonality analysis of cell lineages in acute myeloid leukemia with inversion 16. Cancer Genet Cytogenet (2005) 0.78
Transcription of AML1 in hematopoietic subfractions of normal adults. Ann Hematol (2002) 0.76
Notch signaling controls the generation and differentiation of early T lineage progenitors. Nat Immunol (2005) 3.26
B1b lymphocytes confer T cell-independent long-lasting immunity. Immunity (2004) 2.60
Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia. Cancer Cell (2006) 1.88
The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes. J Immunol (2003) 1.67
B lineage-specific regulation of V(D)J recombinase activity is established in common lymphoid progenitors. J Exp Med (2004) 1.53
Bone marrow microenvironmental changes underlie reduced RAG-mediated recombination and B cell generation in aged mice. J Exp Med (2004) 1.34
Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11. Blood (2004) 1.26
Transitional type 1 and 2 B lymphocyte subsets are differentially responsive to antigen receptor signaling. J Biol Chem (2002) 1.22
EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors. Neuro Oncol (2008) 1.18
Maturation-dependent licensing of naive T cells for rapid TNF production. PLoS One (2010) 1.09
Role of Cbfb in hematopoiesis and perturbations resulting from expression of the leukemogenic fusion gene Cbfb-MYH11. Blood (2002) 1.03
Runx2 induces acute myeloid leukemia in cooperation with Cbfbeta-SMMHC in mice. Blood (2009) 1.03
Divide and conquer: division of labor by B-1 B cells. Immunity (2005) 0.99
B cell receptor-mediated sustained c-Rel activation facilitates late transitional B cell survival through control of B cell activating factor receptor and NF-kappaB2. J Immunol (2009) 0.97
Transitional B cell fate is associated with developmental stage-specific regulation of diacylglycerol and calcium signaling upon B cell receptor engagement. J Immunol (2006) 0.96
Smurf2 regulates the senescence response and suppresses tumorigenesis in mice. Cancer Res (2012) 0.94
Developmental separation of V(D)J recombinase expression and initiation of IgH recombination in B lineage progenitors in vivo. J Exp Med (2004) 0.94
Selection of early-occurring mutations dictates hormone-independent progression in mouse mammary tumor lines. J Virol (2006) 0.91
Progression of pregnancy-dependent mouse mammary tumors after long dormancy periods. Involvement of Wnt pathway activation. Cancer Res (2004) 0.88
CBFB-MYH11 hinders early T-cell development and induces massive cell death in the thymus. Blood (2006) 0.87
Cbfbeta reduces Cbfbeta-SMMHC-associated acute myeloid leukemia in mice. Cancer Res (2006) 0.86
Apurinic/apyrimidinic endonuclease 2 is necessary for normal B cell development and recovery of lymphoid progenitors after chemotherapeutic challenge. J Immunol (2011) 0.85
Bone marrow microenvironmental changes in aged mice compromise V(D)J recombinase activity and B cell generation. Semin Immunol (2005) 0.85
Smurf2 suppresses B-cell proliferation and lymphomagenesis by mediating ubiquitination and degradation of YY1. Nat Commun (2013) 0.83
p37Ing1b regulates B-cell proliferation and cooperates with p53 to suppress diffuse large B-cell lymphomagenesis. Cancer Res (2008) 0.83
Enhancing T lineage production in aged mice: a novel function of Foxn1 in the bone marrow niche. J Immunol (2013) 0.80
A germline point mutation in Runx1 uncouples its role in definitive hematopoiesis from differentiation. Exp Hematol (2013) 0.80
Localized DNA demethylation at recombination intermediates during immunoglobulin heavy chain gene assembly. PLoS Biol (2013) 0.80
Smurf2 regulates hematopoietic stem cell self-renewal and aging. Aging Cell (2014) 0.78
Deciding the decider: Mef2c in hematopoiesis. Nat Immunol (2009) 0.76
Serial transplantation of bone marrow to test self-renewal capacity of hematopoietic stem cells in vivo. Methods Mol Biol (2013) 0.75